143 related articles for article (PubMed ID: 21595537)
21. Drug delivery options for the treatment of ocular inflammation.
Lobo AM; Sobrin L; Papaliodis GN
Semin Ophthalmol; 2010; 25(5-6):283-8. PubMed ID: 21091013
[TBL] [Abstract][Full Text] [Related]
22. Late spontaneous dissociation of a fluocinolone acetonide implant (Retisert).
Rofagha S; Prechanond T; Stewart JM
Ocul Immunol Inflamm; 2013; 21(1):77-8. PubMed ID: 23323586
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous dislocation of fluocinolone acetonide implant pellets from their suture struts.
Itty S; Callanan D; Jones R; Pecen P; Martel J; Jaffe GJ
Am J Ophthalmol; 2015 May; 159(5):868-76.e1. PubMed ID: 25640410
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of fluocinolone acetonide sustained release implant (Retisert) dissociation during implant removal and exchange surgery.
Nicholson BP; Singh RP; Sears JE; Lowder CY; Kaiser PK
Am J Ophthalmol; 2012 Dec; 154(6):969-973.e1. PubMed ID: 22981365
[TBL] [Abstract][Full Text] [Related]
25. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber.
Chang PY; Kresch Z; Samson CM; Gentile RC
Ocul Immunol Inflamm; 2015; 23(6):454-7. PubMed ID: 24724735
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous dislocation of a fluocinolone acetonide implant (Retisert) into the anterior chamber and its successful extraction in sympathetic ophthalmia.
Almeida DR; Chin EK; Mears K; Russell SR; Mahajan VB
Retin Cases Brief Rep; 2015; 9(2):142-4. PubMed ID: 25411930
[TBL] [Abstract][Full Text] [Related]
28. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
29. Cystoid macular edema in a patient with acquired immunodeficiency syndrome and past ocular history of cytomegalovirus retinitis after initiation of protease inhibitors.
Zafirakis P; Markomichelakis NN; Voudouri A; Theodossiadis GP; Theodossiadis PG
Doc Ophthalmol; 1999; 97(3-4):311-5. PubMed ID: 10896344
[TBL] [Abstract][Full Text] [Related]
30. A functional, nonfunctioning Retisert implant.
Hebson CB; Srivastava SK
Ocul Immunol Inflamm; 2011 Jun; 19(3):210-1. PubMed ID: 21595538
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
32. Volumetric analysis of macular edema by scanning laser tomography in immune recovery uveitis.
Bartsch DU; Aurora A; Rodanant N; Cheng L; Freeman WR
Arch Ophthalmol; 2003 Sep; 121(9):1246-51. PubMed ID: 12963607
[TBL] [Abstract][Full Text] [Related]
33. Management of sympathetic ophthalmia with the fluocinolone acetonide implant.
Mahajan VB; Gehrs KM; Goldstein DA; Fischer DH; Lopez JS; Folk JC
Ophthalmology; 2009 Mar; 116(3):552-557.e1. PubMed ID: 19147232
[TBL] [Abstract][Full Text] [Related]
34. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
Khalifa Y; Loh AR; Acharya NR
Ocul Immunol Inflamm; 2009; 17(6):431-3. PubMed ID: 20001265
[TBL] [Abstract][Full Text] [Related]
35. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
Jaffe GJ
Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
[TBL] [Abstract][Full Text] [Related]
36. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Malone PE; Herndon LW; Muir KW; Jaffe GJ
Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
[TBL] [Abstract][Full Text] [Related]
37. Cystoid macular edema in patients with acquired immune deficiency syndrome and cytomegalovirus retinitis.
Eid Farah M; Muccioli C; Rinkevicius M; Barata Lima L; Belfort R
Eur J Ophthalmol; 2000; 10(3):233-8. PubMed ID: 11071031
[TBL] [Abstract][Full Text] [Related]
38. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Silverstein BE; Smith JH; Sykes SO; Jones MR; Schwartz D; Cunningham ET
Am J Ophthalmol; 1998 Mar; 125(3):411-5. PubMed ID: 9512171
[TBL] [Abstract][Full Text] [Related]
39. Decreased visual acuity in patients with cytomegalovirus retinitis and AIDS.
Raina J; Bainbridge JW; Shah SM
Eye (Lond); 2000 Feb; 14 ( Pt 1)():8-12. PubMed ID: 10755092
[TBL] [Abstract][Full Text] [Related]
40. Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.
Cai CX; Skalak C; Keenan RT; Grewal DS; Jaffe GJ
Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1023-1030. PubMed ID: 32114654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
